NASDAQ:RXRX | Total Liabilities | RECURSION PHARMACEUTICALS, INC.

Complete source-backed total liabilities history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Total Liabilities

DateTotal liabilitiesCurrent liabilitiesAccounts payableNoncurrent debtOther noncurrent liabilities
2026-06-30$297.67M$119.89M$12.67M$2.7M
2026-03-31$314.75M$129.7M$20.35M$2.03M
2025-12-31$343.27M$147.71M$18.12M$2.08M
2025-09-30$352.58M$155.1M$13.94M$1.03M
2025-06-30$383.21M$164.03M$19.31M$1.57M
2025-03-31$371.29M$141.98M$25.09M$4.79M
2024-12-31$413.82M$187.47M$21.61M$4.73M
2024-09-30$201.94M$108.89M$2.26M$3M
2024-06-30$191.41M$86.08M$3.76M$3M
2024-03-31$156.7M$73.92M$5.12M
2023-12-31$190.26M$93.17M$3.95M$0.00
2023-09-30$192.86M$94.12M$4.27M
2023-06-30$197.74M$113.96M$2.09M
2023-03-31$197.19M$92.15M$4.25M
2022-12-31$215.48M$100.27M$4.59M
2022-09-30$223.5M$83.04M$3.89M
2022-06-30$234.94M$96.65M$3.18M
2022-03-31$240.75M$85.71M$4.16M
2021-12-31$67.41M$46.66M$2.82M$723,000.00
2021-09-30$59.57M$42.94M$6.33M$744,000.00
2021-06-30$55.88M$29.54M$3.2M$12.66M
2021-03-31$56.66M$26.85M$3.13M$12.68M
2020-12-31$56.56M$23.1M$1.07M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.